Vizora日本語

Nano HoldingsNano Holdings, Inc.4571東証グロース医薬品FY ending Mar 2026, consolidated, J-GAAP

Nano Holdings FY ending Mar 2022 results

Nano Holdings brought in ¥264M in revenue.

It lost about ¥781 for every ¥100 of sales at the operating level.

Revenue changed -15.7% from the prior year.

What changed from last year

FY ending Mar 2021 → FY ending Mar 2022

Revenue
-15.7%¥313.3M → ¥264M
Gross profit
-19.0%¥274.9M → ¥222.7M
Operating income
Loss-¥1.3B → -¥2.06B
Operating cash flow
Loss-¥1.25B → -¥1.75B

Where the money goes

FY ending Mar 2021 → FY ending Mar 2022

Where ¥100 of sales goes

For every ¥100 Nano Holdings sells, how much goes where, and how much is kept.

FY ending Mar 2022
Cost of sales
¥16
SG&A
¥865
Operating loss
¥781
Net loss
¥713

Annual margin trends

Gross margin84.4%
FY ending Mar 2020: 85.9%85.9%FY ending Mar 2021: 87.8%87.8%FY ending Mar 2022: 84.4%84.4%FY20FY21FY22
Operating margin-780.6%
FY ending Mar 2020: -200.0%-200.0%FY ending Mar 2021: -415.9%-415.9%FY ending Mar 2022: -780.6%-780.6%FY20FY21FY22
Net margin-712.7%
FY ending Mar 2020: -363.4%-363.4%FY ending Mar 2021: -905.2%-905.2%FY ending Mar 2022: -712.7%-712.7%FY20FY21FY22

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Sources

Show source documents (2)

  • EDINET (FSA Japan)

    有価証券報告書－第26期(令和3年4月1日－令和4年3月31日)

    ID S100OIP42022-06-28Open

  • EDINET (FSA Japan)

    有価証券報告書－第25期(令和2年4月1日－令和3年3月31日)

    ID S100LR452021-06-25Open

Extracted from XBRL: 42 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image